crowdsourcingThrough crowdsourcing, Protocols.io can provide up-to-date corrections for scientific research protocols.1

Anyone who has taken a general laboratory class knows that the lab manual has multiple protocols that one follows in order to complete each week’s assignment. However, while the class laboratory protocol has been thoroughly tested, academic and industry protocols are often changed and improved as new information is gleaned from previous experiments. A new method can be found to improve the purity and yield of a protein purification, or the incubation time of a transformation is discovered to be optimal at room temperature rather than 42o C. While these types of changes can be tracked within a single lab, protocol changes are usually not noted by the general scientific community until the project is published, which can take many years. ZappyLab, a start up that is dedicated to creating science apps for research and benchwork, has created Protocols.io (beta) in order to remedy this issue. Protocols.io requires crowdsourcing for its success as an up-to-date protocol repository.

Crowdsourcing, or the practice of using data and information from a large number of people, has become increasingly popular with technological advances. The internet and smartphones have globalized information and increased connectivity. Websites such as Wikipedia rely on crowdsourcing for the content generation and the content validation. Scientists should be able to take advantage of crowdsourcing and the increase in information connectivity in conducting effective research.

Projects such as Protocols.io or Experiment.com are examples of the new exciting ways that research is improving, whether through crowdsourcing protocols and increasing protocol accessibility or through crowdfunding of scientific research. While software companies and tech companies such as Mathworks and R have been using crowdsourcing as a way to fix bugs and glitches, biotech companies have only recently used crowdsourcing as a way to improve research methods. After all, the ubiquitous presence of smartphones, tablets, and laptops has increased connectivity, and the scientific community can utilize this increased connectivity to promote and improve research. We at Assay Depot have been an advocate of such connectivity in scientific research, through our free platform to connect scientists to over 10,000 vendor services. However, despite the promise of drastically improving the quality of bench research time, ZappyLab acknowledges that the building of a crowd large enough is the biggest challenge for Protocols’ success, especially as scientists may not think of using an app for their research. ZappyLab has been focused on building their user acquisition for their other science applications and hopes that many current ZappyLab users will continue to use and crowdsource Protocols.

Imagine how much wasted time researchers can save if they are able to connect to an up-to-date protocol. One scientist might spend months optimizing a protocol, and now there is a tool where he can share his insights and potentially save another scientist the wasted months. ZappyLab’s Protocols can become a great resource and benefit all research scientists, as the time will be spent on real breakthroughs rather than re-discovering something that someone else already optimized or discovered. This is one app that the scientific research community should keep an eye on, especially as improvements to research efficiency can promote real discoveries.

References:

  1. http://www.protocols.io/
  2. https://www.kickstarter.com/projects/1881346585/protocolsio-life-sciences-protocol-repository?ref=live
  3. http://www.zappylab.com/
Posted 11:09 am,

Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below it, and a solid foundation is a must. No lofty heights will be reached when the base is not secure. And so, it is not a surprise that a drug discovery project […]

Read More...
Posted 10:36 am,

“Innovation” is suddenly the word on everybody’s lips.  Pfizer launched “Centers for Therapeutic Innovation”, Johnson and Johnson followed with their “Innovation Centres” and now Merck followed with their “Innovation hubs”.  In fact, it happened so fast that many of us in the dusty halls of academia are still trying to get a grip on what’s […]

Read More...
Posted 1:06 pm,

Sometimes, in tragic circumstances, a lesson can be learned and applied in unexpected ways. That appears to be the case with a rare disease that produces debilitating symptoms in children – but might also offer clues to developing a new class of antivirals. The particular disease, an extremely rare congenital disorder called CDG-IIb,  affects the […]

Read More...
Posted 9:52 am,

We have recently discussed here how crowdfunding — donations from the general public in support of a cause, idea, or invention — has caught the attention of scientists seeking financial backing in an era of tight budgets. The brave new world of crowdfunding in science raises questions that defy easy answers. What is essential to […]

Read More...
Posted 12:28 pm,

Connecting academic scientists to the global life science ecosystem Like everyone else, academic researchers are finding that funding sources are drying up and that they somehow must do more research work with less money. To do something about it, a group of Universities in Missouri and Kansas have teamed up with Assay Depot to create […]

Read More...
Posted 11:39 am,

As we previously discussed, CRISPR-mania is sweeping the globe. (Okay, it might not be as big as Beatlemania, but more than a few life science researchers have probably squealed in delight.) The CRISPR system, derived from bacteria’s fight against viruses and tailored so that it can snip away genetic material in other organisms, has generated […]

Read More...
Posted 2:26 pm,

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work — for a while. However, after the respite, the cancer comes roaring back, this time impervious to the once powerful effects of the cancer drugs. Many people would view the disease’s return with resignation […]

Read More...
Posted 1:52 pm,

Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug discoverers.  Now comes the third and final segment and it’s a big one:  Cancer.  For many people the role of the microbiome in inflammation and metabolism is unsurprising.  Your […]

Read More...
Posted 4:08 pm,

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug discovery is that things need to change. Part of the problem is the maze that is human biology. Choosing the “right” drug target is difficult when 1) information is incomplete, […]

Read More...
Posted 11:07 am,